Pfizer, GSK completes transaction to form new consumer healthcare JV Medical Dialogues Bureau3 Aug 2019 9:40 AM ISTThe Joint Venture brings together two highly complementary portfolios of trusted consumer health brands, including GSK's Sensodyne, Voltaren and...
Novartis, Gilead costly cancer therapies Yescarta, Kymriah losing patients to experimental treatments Medical Dialogues Bureau3 Aug 2019 9:15 AM ISTBoth Gilead's Yescarta and Novartis's Kymriah - which are part of a class of therapies known in the medical field as "CAR-T" - were approved in 2017....
Sun Pharma to ramp up global speciality business; eyes "low-to-mid teens" growth in revenues for FY20 Medical Dialogues Bureau1 Aug 2019 10:00 AM ISTThe company is targeting key ailments like psoriasis to gradually ramp up its global speciality business, Dilip Shanghvi said adding that Sun Pharma...
Cadila Healthcare Ankleshwar facility successfully completes USFDA inspection Medical Dialogues Bureau1 Aug 2019 9:25 AM IST"The United States Food and Drug Administration (USFDA) inspected the company's active pharmaceutical ingredient manufacturing facility located at...
Piramal Enterprises Q1 profit rises 21 percent to Rs 461 crore Medical Dialogues Bureau31 July 2019 9:00 AM ISTPiramal Enterprises said its total loan book grew 20 per cent year-on-year to Rs 56,605 crore. The housing finance loan book, which constitutes 11 per...
Pfizer, Mylan in talks to merge off-patent drugs business Medical Dialogues Bureau29 July 2019 9:30 AM ISTMylan shareholders would receive a little more than 40 per cent of the newly formed entity, with Pfizer shareholders receiving the remainder, the...
Novartis CEO Vas Narasimhan vows not to sell Sandoz generics unit Medical Dialogues Bureau29 July 2019 9:17 AM ISTNovartis is revamping Sandoz, a process Narasimhan has previously said will take roughly the next year and a half. He has already sold a generic U.S....
Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel Medical Dialogues Bureau28 July 2019 9:17 AM ISTSales of Eliquis, which Bristol-Myers shares with Pfizer Inc (PFE.N), rose 24% to $2.04 billion, while Orencia sales rose 9% to $778 million, both...
Zydus Cadila launches Ramelteon tablets in US to treat insomnia Medical Dialogues Bureau25 July 2019 11:23 AM ISTIn a BSE filing, Zydus Cadila announced the "launch of Ramelteon tablets, 8 mg upon receiving the final approval from the USFDA. Ramelteon is a...
Pfizer gets USFDA nod for biosimilar to Rituximab Medical Dialogues Bureau25 July 2019 8:59 AM ISTRuxience is a mAb biosimilar to Rituxan which works by targeting a protein called CD20, which is present on the surface of B cells. Ruxience is...
NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister Medical Dialogues Bureau24 July 2019 12:16 PM ISTNPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs 5.56 crore has been...
Torrent Pharma Q1 net profit up 33 percent to Rs 216 crore Medical Dialogues Bureau24 July 2019 9:30 AM ISTThe firm's India business was up nine per cent year-on-year to Rs 907 crore for the quarter. The US revenues at Rs 376 crore were up by 13 per cent...
